Stress-inducible gene Atf3 in the noncancer host cells contributes to chemotherapy-exacerbated breast cancer metastasis
暂无分享,去创建一个
[1] Mei Liu,et al. Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Y. Shaked. Balancing efficacy of and host immune responses to cancer therapy: the yin and yang effects , 2016, Nature Reviews Clinical Oncology.
[3] Jindan Yu,et al. The common stress responsive transcription factor ATF3 binds genomic sites enriched with p300 and H3K27ac for transcriptional regulation , 2016, BMC Genomics.
[4] I. Keklikoglou,et al. Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy. , 2015, Cancer research.
[5] Yarong Wang,et al. Real-Time Imaging Reveals Local, Transient Vascular Permeability, and Tumor Cell Intravasation Stimulated by TIE2hi Macrophage-Derived VEGFA. , 2015, Cancer discovery.
[6] J. Bergh,et al. Gene expression profiling of sequential metastatic biopsies for biomarker discovery in breast cancer , 2015, Molecular oncology.
[7] S. Ran. The Role of TLR4 in Chemotherapy-Driven Metastasis. , 2015, Cancer research.
[8] Brian Ruffell,et al. Macrophages and therapeutic resistance in cancer. , 2015, Cancer cell.
[9] Vivien W. Chan,et al. Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells. , 2014, Cancer cell.
[10] S. Ran,et al. Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner. , 2014, Cancer research.
[11] T. Rohan,et al. Tumor microenvironment of metastasis and risk of distant metastasis of breast cancer. , 2014, Journal of the National Cancer Institute.
[12] Jeffrey W Pollard,et al. Tumor-associated macrophages: from mechanisms to therapy. , 2014, Immunity.
[13] D. Munn,et al. Immunosuppressive myeloid cells induced by chemotherapy attenuate antitumor CD4+ T-cell responses through the PD-1-PD-L1 axis. , 2014, Cancer research.
[14] S. Stacker,et al. Lymphangiogenesis and lymphatic vessel remodelling in cancer , 2014, Nature Reviews Cancer.
[15] D. Linehan,et al. Targeting tumor-infiltrating macrophages to combat cancer. , 2013, Immunotherapy.
[16] J. Condeelis,et al. Macrophage contact induces RhoA GTPase signaling to trigger tumor cell intravasation , 2013, Oncogene.
[17] Michael C. Ostrowski,et al. Transcription factor ATF3 links host adaptive response to breast cancer metastasis. , 2013, The Journal of clinical investigation.
[18] Jonathan B. Mitchem,et al. Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis , 2013, Clinical Cancer Research.
[19] C. Lewis,et al. Macrophage regulation of tumor responses to anticancer therapies. , 2013, Cancer cell.
[20] Jonathan B. Mitchem,et al. Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses. , 2013, Cancer research.
[21] Wilfrid Boireau,et al. Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth , 2012, Nature Medicine.
[22] Sangdun Choi,et al. Doxorubicin Induces Cytotoxicity through Upregulation of pERK–Dependent ATF3 , 2012, PloS one.
[23] Raymond K. Auerbach,et al. An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.
[24] Z. Werb,et al. Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance. , 2012, Cancer cell.
[25] L. Coussens,et al. Immune microenvironments in solid tumors: new targets for therapy. , 2011, Genes & development.
[26] E. Brogi,et al. Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer. , 2011, Genes & development.
[27] E. Voest,et al. Chemotherapy enhances metastasis formation via VEGFR-1-expressing endothelial cells. , 2011, Cancer research.
[28] T. Voloshin,et al. Host response to short-term, single-agent chemotherapy induces matrix metalloproteinase-9 expression and accelerates metastasis in mice. , 2011, Cancer research.
[29] Robert A. Weinberg,et al. Tumor Metastasis: Molecular Insights and Evolving Paradigms , 2011, Cell.
[30] L. Elia,et al. A Cell-Based High-Content Screening Assay Reveals Activators and Inhibitors of Cancer Cell Invasion , 2011, Science Signaling.
[31] Hideaki Tahara,et al. Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells , 2011, Proceedings of the National Academy of Sciences.
[32] Luke A. Gilbert,et al. Chemotherapeutic resistance: surviving stressful situations. , 2011, Cancer research.
[33] Jinghang Zhang,et al. CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasis , 2011, Nature.
[34] Karin Jirström,et al. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. , 2011, Cancer discovery.
[35] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[36] R. Kerbel,et al. Cancer: Chemotherapy counteracted , 2010, Nature.
[37] R. Young,et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state , 2010, Proceedings of the National Academy of Sciences.
[38] Luke A. Gilbert,et al. DNA Damage-Mediated Induction of a Chemoresistant Niche , 2010, Cell.
[39] Tsonwin Hai,et al. Cisplatin induces cytotoxicity through the mitogen-activated protein kinase pathways and activating transcription factor 3. , 2010, Neoplasia.
[40] Tsonwin Hai,et al. ATF3, a hub of the cellular adaptive-response network, in the pathogenesis of diseases: is modulation of inflammation a unifying component? , 2010, Gene expression.
[41] Philip S Rosenberg,et al. Male breast cancer: a population-based comparison with female breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[42] Ruth J. Muschel,et al. A Distinct Macrophage Population Mediates Metastatic Breast Cancer Cell Extravasation, Establishment and Growth , 2009, PloS one.
[43] John S. Condeelis,et al. Tumor Microenvironment of Metastasis in Human Breast Carcinoma: A Potential Prognostic Marker Linked to Hematogenous Dissemination , 2009, Clinical Cancer Research.
[44] A. Visel,et al. ChIP-seq accurately predicts tissue-specific activity of enhancers , 2009, Nature.
[45] A. C. Wang,et al. Role of TLR4 for paclitaxel chemotherapy in human epithelial ovarian cancer cells , 2009, European journal of clinical investigation.
[46] R. Kerbel,et al. Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents. , 2008, Cancer cell.
[47] P. Allavena,et al. Cancer-related inflammation , 2008, Nature.
[48] S. I. Park,et al. Role of Activating Transcription Factor 3 on TAp73 Stability and Apoptosis in Paclitaxel-Treated Cervical Cancer Cells , 2008, Molecular Cancer Research.
[49] John N Weinstein,et al. A stromal gene signature associated with inflammatory breast cancer , 2008, International journal of cancer.
[50] Tsonwin Hai,et al. A potential dichotomous role of ATF3, an adaptive-response gene, in cancer development , 2007, Oncogene.
[51] Frank Rose,et al. Metastasis: the seed and soil theory gains identity , 2007, Cancer and Metastasis Reviews.
[52] J. Segall,et al. Coordinated regulation of pathways for enhanced cell motility and chemotaxis is conserved in rat and mouse mammary tumors. , 2007, Cancer research.
[53] L. Coussens,et al. Humoral immunity, inflammation and cancer. , 2007, Current opinion in immunology.
[54] Yarong Wang,et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. , 2007, Cancer research.
[55] E. Stanley,et al. Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts. , 2006, Cancer research.
[56] Tsonwin Hai,et al. Activating Transcription Factor 3, a Stress-inducible Gene, Suppresses Ras-stimulated Tumorigenesis* , 2006, Journal of Biological Chemistry.
[57] M. Mottolese,et al. The Cytoskeleton Regulatory Protein hMena (ENAH) Is Overexpressed in Human Benign Breast Lesions with High Risk of Transformation and Human Epidermal Growth Factor Receptor-2–Positive/Hormonal Receptor–Negative Tumors , 2006, Clinical Cancer Research.
[58] S. Rafii,et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.
[59] Luigi Naldini,et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. , 2005, Cancer cell.
[60] John S. Condeelis,et al. Identification and Testing of a Gene Expression Signature of Invasive Carcinoma Cells within Primary Mammary Tumors , 2004, Cancer Research.
[61] Steffen Jung,et al. Blood monocytes consist of two principal subsets with distinct migratory properties. , 2003, Immunity.
[62] N. Ferrara,et al. The biology of VEGF and its receptors , 2003, Nature Medicine.
[63] M. Barry,et al. Cytotoxic T lymphocytes: all roads lead to death , 2002, Nature Reviews Immunology.
[64] Tsonwin Hai,et al. The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. , 2001, Gene.
[65] L. Saltz,et al. New therapies, new directions: advances in the systemic treatment of metastatic colorectal cancer. , 2001, The Lancet. Oncology.
[66] Alberto Mantovani,et al. Inflammation and cancer: back to Virchow? , 2001, The Lancet.
[67] A. Pileri,et al. Clinical relevance of minimal residual disease monitoring in non-Hodgkin’s lymphomas: a critical reappraisal of molecular strategies , 1999, Leukemia.
[68] I. M. Neiman,et al. [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.
[69] Akiko Sakai,et al. Comparative proteomic analysis of paclitaxel resistance-related proteins in human breast cancer cell lines. , 2017, Oncology letters.
[70] Tsonwin Hai,et al. Immunohistochemical detection of activating transcription factor 3, a hub of the cellular adaptive-response network. , 2011, Methods in enzymology.
[71] G. Hortobagyi,et al. Overview of resistance to systemic therapy in patients with breast cancer. , 2007, Advances in experimental medicine and biology.
[72] J. Gregg,et al. Syngeneic mouse mammary carcinoma cell lines: Two closely related cell lines with divergent metastatic behavior , 2005, Clinical & Experimental Metastasis.
[73] R. Dickson,et al. Explant-cell culture of primary mammary tumors from MMTV-c-Myc transgenic mice , 2004, In Vitro Cellular & Developmental Biology - Animal.
[74] Tsonwin Hai,et al. ATF3 and stress responses. , 1999, Gene expression.
[75] J. Beijnen,et al. Preclinical pharmacokinetics of paclitaxel and docetaxel. , 1998, Anti-cancer drugs.
[76] M. Montminy,et al. Transcriptional regulation by cyclic AMP. , 1997, Annual review of biochemistry.